³ì³»Àå

Áø´Ü(±¹½ÃÃ¥)

¾È¾Ð 21mmhgÀÌ»ó

CD ratio cup/disk ratio 0.6ÀÌ»ó

µÎ´« CD ratio Â÷ÀÌ 0.2 ÀÌ»ó

¾çÃø ¾È¾ÐÂ÷ÀÌ 5mmhg

 

Æó¼â°¢ ³ì³»Àå

¹æ¼öÀÇ »ý¼º°ú À¯ÃâÀÇ ±ÕÇüÀÌ ¹«³ÊÁ®¼­ ¹ß»ýÇÔ

 

Áõ»ó

¡¤         Decreased vision

¡¤         Halos around lights

¡¤         Headache

¡¤         Severe eye pain

¡¤         Nausea and vomiting

 

 

Áø´Ü

 

 

http://www.goodhopeeyeclinic.org.uk/images/anglebiomicroscopy.jpg

 

±Þ¼º Æó¼â°¢ ³ì³»Àå

1½Ã°£³»¿¡ ¾È°ú¿¡ º¸³»¶ó

±×·¸Áö ¸øÇÒ¶§´Â ÀÀ±Þ óġÇ϶ó

¾Æ·¡ÀÇ regimenÀ» ºÐ´ç1ȸ Åõ¿©

¡¤         0.5% timolol maleate (Timoptic) nonselective beta-blocker , Blocks both beta1- and beta2-adrenergic receptors, reduces intraocular pressure by reducing aqueous humor production or possibly outflow

¡¤         1% apraclonidine (Iopidine), and potent alpha-adrenergic agent ,  ¹æ¼öÀÇ »ý¼ºÀ» ÁÙÀÓ

¡¤         2% pilocarpine (Isopto Carpine) Directly stimulates cholinergic receptors in the eye causing miosis , loss of accommodation (by constriction of ciliary muscle)

ÇÊ·ÎÄ®ÇÉ Mechanism of Action (Ãൿ, ¼¶¸ðü±ÙÀ° ¼öÃà)

Directly stimulates cholinergic receptors in the eye causing miosis (by contraction of the iris sphincter), loss of accommodation (by constriction of ciliary muscle), and lowering of intraocular pressure (with decreased resistance to aqueous humor outflow)

¼¶¸ðü ±ÙÀ°ÀÌ ¼öÃàÇÒ¶§ trabecular meshwork¸¦ ¿­¾î¼­ ¹æ¼ö À¯ÃâÀ» µ½°Ô µÈ´Ù

 

oral or IV acetazolamide, IV mannitol, or oral glycerol or isosorbide¸¦ ÀÚÁÖÁÙ¼ö ÀÖ´Ù.

   uptodateÃßõ 250mg oral acetazolamide

¡¤  Carbonic Anhydrase Inhibitor ÀÏÁ¾ÀÇ diuretics(¹æ¼öÀÇ »ý¼ºÀ» ÁÙÀ̴µ¥ ¾²´Â)

 

´Ù¸¥ ¾àÀº ¾È°ú¿¡¼­ ½á¶ó. ¿Ö³ªÇϸé angle closure°¡ È®ÀÎÀÌ µÇ¾î¾ß ÇÑ´Ù.

AttackÀÌ Áö³ª°¡¸é laser iridotomy¸¦ ÇØ¾ßÇÔ. ±×°Íµµ À߾ȵǸé, peripheral iridectomy

http://1.bp.blogspot.com/_QLeKhMxmr4M/TGGaBEzFrKI/AAAAAAAAANw/sppYoUWcmKA/s1600/peripheral+iridotomy.jpg

http://webeye.ophth.uiowa.edu/eyeforum/Images/glaucoma/9-4C-D.gif

 

 

°³¹æ°¢ ³ì³»Àå

Ä¡·á½ÃÀÛ ¾È¾Ð: consensus´Â ¾ø´Ù.

  case by case

  IOP 22 to 24 mmHg À̸鼭 optic nerve ±¦Âú°í, visual field ±¦ÂúÀ¸¸é Ä¡·á ¾ÈÇÒ¼ö ÀÖ°í

  IOP 18mmhg À̸鼭 visual field ³ª»Ú°í, cuppingÀÌ °üÂûµÇ¸é Ä¡·áÇÑ´Ù.

 

¸ñÇ¥ ¾È¾Ð :  IOP of ¡Ã25 to 30 percent below initial IOP

 

Ä¡·á

 

º¸Åë ¸î°¡Áö ¾àÁ¦¸¦ Åõ¿©ÇÏ°Ô µÈ´Ù.

ÇÏ·ç 3~4ȸ Åõ¿©ÇÏ°Ô µÈ´Ù.

 

BB : ¹æ¼ö »ý¼º ¾ïÁ¦

 

topical prostaglandins(Æ÷µµ¸· °ø¸· À¯ÃâÀ» Áõ°¡½ÃÄÑ ¾È¾Ð°¨¼Ò)

   as initial therapy·Î Ãßõ

   effective and well tolerated, with few systemic side effects

   latanoprost ÀÌ hyperemia ºÎÀÛ¿ëÀÌ Àû´Ù

 

Alpha adrenergic agonists

   beta blockers¿Í ºñ½ÁÇÑ È¿°ú

   ´« ºÎÀÛ¿ë ¸¹´Ù : allergic conjunctivitis, hyperemia, and ocular pruritis

 

Systemic carbonic anhydrase inhibitors

   »õ·Î¿î topical¿¡ ¸¹ÀÌ ´ëÄ¡µÇ¾ú´Ù.

   Topical carbonic anhydrase inhibitors´Â ´Ù¸¥ ¸Ô´Â ¾à¹°º¸´Ù È¿°ú°¡ ¶³¾îÁø´Ù.

 

Cholinergic agonists

   beta-blockerº¸´Ù Àü½ÅÀûÀÎ ºÎÀÛ¿ë Àû´Ù

   small pupils, myopia, and increased subjective visual disturbance °°Àº ºÎÀÛ¿ë¶§¹®¿¡ ÀαⰡ ÁÙ¾ú´Ù.

 

 

 

¿©±â±îÁö uptodate 19.3